Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
Today's Change
Volume
Real-Time Last Update CSE Last Sale

More stories below advertisement

CanaFarma Hemp Products Corp. Partners with APeT BV to Develop a Novel Hemp-Based Cannabinoid Capsule Delivery Mechanism

ACCESSWIRE - Wed Sep 16, 1:00AM CDT

This news release is not for distribution or dissemination in the United States of America

VANCOUVER, BC / ACCESSWIRE / September 16, 2020 / CanaFarma Hemp Products Corp. (CNSX:CNFA.CN) (the "Corporation" or "CanaFarma") has partnered with APeT BV to develop novel Hemp-based cannabinoid, drug and nutritional supplement delivery methods via its FLOTEXaEURC patented technology. FLOTEXaEURC is a unique, patented, floating technology designed for safer and more effective delivery of active ingredients. FLOTEXaEURC is a GastroaEURRetentive Drug Delivery System ("GRDDS"), whereby active ingredients are delivered in a time released manner via a capsule that "floats" within the stomach. FLOTEXaEURC has excellent floating capacity of at least 24 hours, whereby buoyancy increases in time thanks to the steady floating chamber.

The collaboration between the two companies will use the APeT BV FLOTEXaEURC technology to create novel approaches to infusing Hemp-based cannabinoids into a safer, self-repairing, better performing, gastro-retentive, controlled-release delivery platform for pharmaceuticals and nutraceuticals. Focus will be on anti-viral, immune boosting and anti-aging formulations.

Many patients are suffering from side effects from, or lack of efficacy of, their medication(s). Additionally, therapy compliance challenges such as too many pills spread over different hours of intake per day, can lead to skipping/forgetting to take the right amount of medication at the right time, or stopping the therapy all together. Canafarma and APeT's use of the FLOTEXaEURC technology will be designed with the objective of resolving many of these problems.

David Lonsdale, CEO of CanaFarma said, "We are delighted to be working with APeT on something so important to the industry, and our initial focus will be on anti-viral, immune boosting and anti-aging formulations to further develop the Company's consumer product brands."

About CanaFarma Hemp Products Corp.

CanaFarma Hemp Products Corp. is a full-service company operating in the hemp industry offering a full range of hemp-related products and services to the consumer wellness market. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a well-established direct-to-consumer marketing approach.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

FOR FURTHER INFORMATION, PLEASE CONTACT:

David LonsdaleChief Executive OfficerPhone: (214) 704-7942Email: david@canafarmacorp.com

SOURCE: CanaFarma Hemp Products Corp.

View source version on accesswire.com: https://www.accesswire.com/606140/CanaFarma-Hemp-Products-Corp-Partners-with-APeT-BV-to-Develop-a-Novel-Hemp-Based-Cannabinoid-Capsule-Delivery-Mechanism

comtex tracking

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies